Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CD388 prophylaxis in influenza challenge
NCT05523089Phase 2Completed
- Sponsor
- Cidara Therapeutics
- Start
- Sep 2022
- Primary completion
- Jul 2023
- Modality
- Small Molecules, Fc Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of retezrelvir in influenza, sponsored by Cidara Therapeutics. Started Sep 2022; status: completed.
02
Drugs
retezrelvir
03
Conditions
influenza
Beyond the preview
Go deeper on NCT05523089.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05523089.